Women living with diabetes: Overlooked and under‐recognised, the psychosocial impact Authors: Rita Forde, Angus Forbes, Dawn Adams, Aycan Celik Esmer, Emma Davidsen, Maartje de Wit, Michelle Hadjiconstantinou, Rahab Hashim, Ana Munda, Giesje Nefs, Hermelinda C. Pedrosa, Anita Sabidi, Judith Parsons Published: 2026 ABSTRACT AbstractAimDiabetes intersects with women's reproductive and sexual health across the life course; however, the psychosocial implications of key reproductive transitions remain under‐recognised in research and clinical practice. This review synthesised evidence on the psychosocial impacts of diabetes during menstruation, pregnancy, the menopausal transition and sexual functioning, with the aim of identifying critical gaps in research and care.MethodsA narrative review was conducted, informed by a semi‐structured literature search.FindingsWomen living with diabetes experience substantial psychosocial burdens that extend beyond glycaemic management across all reproductive stages. During menstruation, hormonal fluctuations contribute to glycaemic variability, increased self‐management demands and emotional distress, often without adequate clinical guidance. Pregnancy in women with type 1, type 2, and gestational diabetes is associated with heightened anxiety, diabetes distress, stigma and guilt, yet psychosocial needs remain largely unaddressed in routine care. The menopausal transition represents a further period of vulnerability, characterised by worsening glycaemic variability, increased psychological morbidity and elevated cardiovascular risk. Sexual dysfunction is highly prevalent across the lifespan in women with diabetes and is strongly associated with depression, anxiety and body image concerns.ConclusionOverall, the evidence highlights a persistent disconnect between the psychosocial needs of women and the predominantly biomedical focus of current diabetes care models. Addressing this gap requires a person‐centred approach that integrates psychosocial and women‐specific health considerations into diabetes research, education and clinical practice. Strengthening this evidence base is essential to improving long‐term health outcomes for women living with diabetes. What's new?What is known? Women's health is largely overlooked clinically and underrepresented in diabetes research with little focus on psychosocial perspectives. What this study found? Diabetes interacts with hormone‐mediated transitions complicating glycaemia and psychosocial health. Menstruation, pregnancy, and menopause are associated with increased glycaemic variability, emotional distress, and heightened self‐management burden, while also exposing women to stigma and adverse social experiences. Sexual dysfunction is highly prevalent among women with diabetes, reflecting complex biopsychosocial mechanisms. What are the implications? Women with diabetes require clinically informed care that explicitly addresses psychosocial factors, supported by expanded women‐centred research across all diabetes types. What's new? What is known? Women's health is largely overlooked clinically and underrepresented in diabetes research with little focus on psychosocial perspectives. Women's health is largely overlooked clinically and underrepresented in diabetes research with little focus on psychosocial perspectives. Women's health is largely overlooked clinically and underrepresented in diabetes research with little focus on psychosocial perspectives. What this study found? Diabetes interacts with hormone‐mediated transitions complicating glycaemia and psychosocial health. Menstruation, pregnancy, and menopause are associated with increased glycaemic variability, emotional distress, and heightened self‐management burden, while also exposing women to stigma and adverse social experiences. Sexual dysfunction is highly prevalent among women with diabetes, reflecting complex biopsychosocial mechanisms. Diabetes interacts with hormone‐mediated transitions complicating glycaemia and psychosocial health. Menstruation, pregnancy, and menopause are associated with increased glycaemic variability, emotional distress, and heightened self‐management burden, while also exposing women to stigma and adverse social experiences. Sexual dysfunction is highly prevalent among women with diabetes, reflecting complex biopsychosocial mechanisms. Diabetes interacts with hormone‐mediated transitions complicating glycaemia and psychosocial health. Menstruation, pregnancy, and menopause are associated with increased glycaemic variability, emotional distress, and heightened self‐management burden, while also exposing women to stigma and adverse social experiences. Sexual dysfunction is highly prevalent among women with diabetes, reflecting complex biopsychosocial mechanisms. What are the implications? Women with diabetes require clinically informed care that explicitly addresses psychosocial factors, supported by expanded women‐centred research across all diabetes types. Women with diabetes require clinically informed care that explicitly addresses psychosocial factors, supported by expanded women‐centred research across all diabetes types. Women with diabetes require clinically informed care that explicitly addresses psychosocial factors, supported by expanded women‐centred research across all diabetes types. INTRODUCTION People living with diabetes and their families encounter complex and multidimensional issues when integrating diabetes care into their daily life. 1 Diabetes is one of the most common chronic conditions affecting women, with the global prevalence continuing to rise. The incidence of type 1 diabetes, type 2 diabetes 2 and gestational diabetes (GDM) has been increasing for several decades. 3 , 4 Recent estimates suggest that 589 million adults (20–79 years), approximately 11.1% of the global population are living with diabetes. 3 Type 2 diabetes accounts for most cases of diabetes, while type 1 diabetes affects approximately 9 million individuals worldwide, and GDM impacts an estimated one in six births globally. 3 , 4 While diabetes affects both men and women, its implications for women's health are distinct and shaped by the reproductive life cycle. Across menstruation, reproductive health, pregnancy, menopause, and sexual function, diabetes intersects with hormonal, physiological, and social changes, impacting both diabetes management and overall psychological well‐being. 1 The impact of diabetes extends beyond physical symptoms. Psychosocial factors including behavioural, emotional, social, and environmental influences greatly impact diabetes self‐management and psychological health. 1 Emerging evidence suggests that women experience a disproportionate psychosocial burden related to diabetes care compared with men. 5 , 6 This burden is amplified by structural and systemic inequities. Women are more likely to experience a longer time to diagnosis than men, even when presenting with similar clinical features. 7 In addition, women are more likely to experience diabetes‐related distress and to be prescribed treatment for depression and anxiety. 6 These disparities are further shaped by social and cultural determinants of health. Gendered expectations, including caregiving roles and competing responsibilities, can influence how women prioritise their own health and engage with diabetes management. 8 In low‐ and middle‐income settings, these challenges may be increased by economic, political, and social disadvantages, contributing to poorer health outcomes and reduced access to care. 9 Despite this, the psychosocial dimensions of diabetes in women remain under‐recognised in both research and clinical practice. 10 , 11 , 12 Existing evidence has mainly examined the psychosocial impacts of diabetes within discrete stages of women's health, most commonly during pregnancy, with comparatively less attention to other phases of the reproductive lifecycle. This approach limits understanding of how psychosocial burden evolves over time and across transitions. There is a need for a more integrated, life‐course perspective that captures the growing and intersecting influences of biological, psychological, and social factors on women's experiences of diabetes. To address this gap, this narrative review synthesises the psychosocial impacts of diabetes across key aspects of women's health, including menstruation, pregnancy, menopause, and sexual function. A semi‐structured literature search was undertaken, with studies selected based on their relevance and contribution. 13 The evidence was synthesised using a thematic, interpretive approach. 13 , 14 This review aims to provide a comprehensive understanding of the unique challenges faced by women living with diabetes and to identify critical gaps in the evidence base to inform future research, policy, and clinical care (Table 1). TABLE 1Diabetes and women's health.DomainDimensionsConsequenceEvidence gapsMenstruationHormonal‐driven glycaemic variabilityIncreased burden, distress, reduced QoLLimited guidance; poor clinician awarenessPregnancyType 1 diabetesStigma; High treatment demandsDistress, fear, guiltLimited/No psychosocial interventionsType 2 diabetesStigma; unmet reproductive needsDistress, stigma fear, reduced engagementNo psychosocial interventionsGestational diabetesDiagnosis shock; lifestyle burdenAnxiety, stigmaLimited/No psychosocial integration in careStigmaWeight/blame narrativesDistress, care avoidanceLimited/No intervention researchMental healthIncreased depression/anxietyLimited self‐managementLimited data/No screening pathwaysDiabetes distressAcross pre‐, peri‐, post‐pregnancyLoss of controlNo care pathwaysSocial supportPeer/family bufferingImproved copingLimited/No modelsMenopauseMenopauseHormonal instability; increased variabilityBurnout; reduced QoLLimited/No data; No guidanceMental healthIncreased cognitive burdenAnxiety; disengagementNo tailored strategiesCardiovascular riskIncreased mortalityMajor morbidityModels lack sex/psychosocial factorsHealthcare experienceFeeling dismissedReduced help‐seekingTraining gaps/No interventionsSexual functionSexual functionHigh sexual dysfunction prevalenceReduced QoL; relationship strainUnderdiagnosed; Limited/No interventionsPsychosocial driversDepression, body imageAvoidance; distressLimited dataTechnology and intimacyDevice burdenBody image; reduced intimacyLimited/No evidenceClinical integrationRarely addressedUnmet needsNo screening/treatment pathwaysAbbreviation: QoL, quality of life. Diabetes and women's health. Abbreviation: QoL, quality of life. MENSTRUATION AND DIABETES Menstruation can complicate glucose regulation, impacting how women experience and manage their diabetes. 15 The cyclical hormonal changes contribute to fluctuations in glucose levels, increasing the demands on diabetes self‐management. A recent online survey of participants from the United States (n = 686) and Europe (n = 899) found that 60% of those with type 1 diabetes and 23% of those with type 2 diabetes reported their menstrual cycle adversely affects their diabetes and its management. However, only a third of participants had discussed the impact of menstruation with their healthcare providers, and such conversations were more likely among those living with type 1 diabetes compared with those with type 2 diabetes. 16 Hormonal impact Fluctuations in oestrogen and progesterone have been shown to reduce insulin sensitivity during the second phase of the menstrual cycle (the luteal phase), potentially resulting in hyperglycaemia. 17 , 18 Many women are unaware of the physiological factors influencing glucose variability, requiring menstruating women to develop individualised strategies to adjust treatment, 19 frequently leading to feelings of frustration. 20 Thus, menstruation represents an added challenge to achieving glycaemic stability and maintaining daily functioning. 21 There is some evidence suggesting that women only became aware of the cyclical nature of their glucose variability when using technology such as Open Source Automated Insulin Delivery (AID) systems and had to compensate for these fluctuations. 19 , 20 Menstrual dysfunction A meta‐analysis of 12 studies including women with type 1 diabetes (n = 1615) reported that menstrual irregularities, such as infrequent or absent menstrual periods, occur more often in women with type 1 diabetes compared with age‐matched women without diabetes (odds ratio 2.08). 19 The analysis also indicated that the average age at menarche is approximately 0.42–0.53 years later in girls with type 1 diabetes, although this is still within the typical pubertal range. 19 A later onset of menstruation was associated with higher HbA1c levels and greater insulin requirements. 19 , 22 Menstrual abnormalities were not correlated to HbA1c levels or a person's body weight. However, menstrual abnormalities were more common in those with a longer duration of diabetes. 19 While more prevalent among those with type 1 diabetes, irregular menstrual cycles are also commonly reported among women with type 2 diabetes. 23 Excess body weight and obesity constitute major risk factors for menstrual abnormalities such as polyendocrine metabolic ovarian syndrome (PMOS) and premenstrual disorders owing to their links with insulin resistance and hormonal dysregulation. 24 Consequently, longer and irregular menstrual cycles have also been associated with an elevated risk of developing cardiovascular disease in women. 25 , 26 Glycaemic variability The need to adapt treatment regimens in response to hormonal fluctuations can heighten emotional burden for women. 20 For many, the monthly recurrence of unpredictable glycaemic variability promotes a sense of frustration. This was coupled with a lack of information, awareness, and limited guidance from healthcare providers. 20 Qualitative reports from diabetes communities describe recurrent frustration, anxiety, and a pervasive sense of ‘losing control’ around menstruation. 27 This potentially exacerbates diabetes‐related distress and diminishes quality of life. 28 Self‐management Many women report receiving limited guidance from healthcare professionals on how to modify insulin regimens in response to menstrual cycle‐related changes. Health‐seeking behaviours can be negatively impacted by societal norms associated with menses stigma. 29 , 30 In addition, adult women often need to navigate their menstrual health with caregiving and work responsibilities, while those approaching menopause experience further hormonal variations that influence insulin sensitivity. 31 Sex‐specific considerations need to be integrated into diabetes care and education. Healthcare professionals often lack awareness of the menstrual cycle's impact on glycaemia. This absence reflects broader sex biases in medical research, where women‐specific variables are frequently excluded from clinical trials. 32 Despite the impact of the menstrual cycle on diabetes management, menstrual health including the psychosocial impact remains underexplored and generally absent from diabetes care. Cultural and ethnic dimensions of menstruation in diabetes care Cultural practices deeply shape women's experiences of menstruation. In some cultures, menstruating women are considered ‘impure’ and are required to isolate from family and community spaces. 33 , 34 For women with diabetes, this cultural isolation can disrupt access to insulin, glucose monitoring, and adequate nutrition, directly endangering health. 34 Menstrual stigma reduces healthcare‐seeking behaviour and impedes chronic illness management. 25 The intersection between diabetes and menstruation exacerbates vulnerability as women from marginalised ethnic groups and rural communities face systemic barriers, including limited healthcare infrastructure and a lack of culturally sensitive diabetes care. 35 , 36 Evidence gaps and conclusion To generate a more complete account of the complexity of menstruation on the daily lives and overall well‐being of women with diabetes, future research should consider: Developing a multidimensional understanding of the impact of the menstrual cycle on diabetes management by combining physiological measures with validated psychosocial outcomes.Addressing the limited evidence of women's perspectives, exploring how menstruation shapes their daily self‐management practices, emotional labour, and interactions with healthcare services.Designing and evaluating educational and clinical interventions to support a more responsive and inclusive approach to diabetes care for women during this phase of life. Developing a multidimensional understanding of the impact of the menstrual cycle on diabetes management by combining physiological measures with validated psychosocial outcomes. Developing a multidimensional understanding of the impact of the menstrual cycle on diabetes management by combining physiological measures with validated psychosocial outcomes. Addressing the limited evidence of women's perspectives, exploring how menstruation shapes their daily self‐management practices, emotional labour, and interactions with healthcare services. Addressing the limited evidence of women's perspectives, exploring how menstruation shapes their daily self‐management practices, emotional labour, and interactions with healthcare services. Designing and evaluating educational and clinical interventions to support a more responsive and inclusive approach to diabetes care for women during this phase of life. Designing and evaluating educational and clinical interventions to support a more responsive and inclusive approach to diabetes care for women during this phase of life. Interactions between menstruation and diabetes self‐management are complex, influencing emotional well‐being, perceived control and everyday life, which are not reflected by biomedical metrics alone. Current research remains disproportionately focused on the physiological impact with limited attention to the psychosocial experiences. Advancing person‐centred diabetes care requires an evidence base that integrates metabolic data with psychosocial measures and lived experiences. Such an approach is crucial to inform clinical guidance and care for menstruating women living with diabetes. PREGNANCY AND DIABETES Diabetes is the most common co‐morbid condition of pregnancy, affecting around 23 million live births globally per year (15.6%). 37 The incidence of pregnancies complicated by diabetes is increasing. 38 Management requires intensive intervention to maintain blood glucose within a narrow therapeutic range to minimise adverse birth outcomes. Such intervention is required throughout pregnancy and for women with pre‐existing diabetes, in the period prior to pregnancy. Pregnancy, independent of diabetes, is a period of transition and can introduce feelings of uncertainty and anxiety. 39 For women with diabetes, these feelings are amplified by the demands of intensive management, monitoring and treatment, creating additional psychosocial challenges. A review of the evidence on AID in pregnancy among women with type 1 diabetes indicates emerging, albeit insufficient, evidence of psychosocial benefit, underscoring the need for adequately powered, pregnancy‐specific studies incorporating validated psychosocial outcomes. 40 We review here evidence relating to psychosocial issues in pregnancy for women with type 1, type 2, and gestational diabetes (GDM). While a substantial body of research addresses GDM, evidence concerning type 1 diabetes and especially type 2 diabetes is far more limited. Women with type 1 and type 2 diabetes face overlapping as well as distinct challenges. Prior to pregnancy qualitative syntheses of studies of women with type 1 diabetes 41 and type 2 diabetes 42 , 43 report feelings of fear, and anxiety related to a perceived loss of control over their reproductive intentions and the health of a future child. Women with type 1 diabetes experience heightened anxiety, diabetes distress, and a strong sense of responsibility for maternal and fetal outcomes during pregnancy. 44 , 45 This is a particularly vulnerable time as the psychosocial burden remains under‐researched and often overlooked in both clinical practice and policy. 41 For women with type 2 diabetes psychosocial difficulties can be shaped by broader social narratives that frame type 2 diabetes as a condition due to personal health practices, alongside limited consideration of reproductive health needs. 42 , 43 GDM, the most common form of diabetes in pregnancy (affecting approximately one in seven women worldwide) 37 is particularly well studied in terms of psychosocial challenges, which extend beyond individual emotional responses, encompassing social dynamics, identity disruption, and interactions with family and healthcare systems. Diagnosis often introduces significant psychological distress, characterised by shock, anxiety, and a sense of deviation from a ‘normal’ pregnancy. 46 This shift to a high‐risk medicalised pregnancy can be disorienting, especially when accompanied by messages that place strong emphasis on individual responsibility for health outcomes. 47 Nevertheless, the psychological burden of GDM remains under‐recognised in clinical practice. In low and middle income countries (LMICs) these impacts may be amplified as women face additional challenges due to systemic, cultural, and health system barriers. 48 Stigma Although evidence for pre‐existing diabetes is limited, one qualitative study reported that stigma and self‐blame may negatively impact women with type 2 diabetes' access to pre‐pregnancy care through reduced care engagement and under consideration of their reproductive potential. 49 In addition, weight stigma (which affects some women with diabetes) in pregnancy was associated with a 40% increased risk of anxiety or depression in a North American survey (n = 463). 50 Women with type 1 diabetes frequently experience internalised blame and worry about adverse pregnancy outcomes.51,52 These experiences may be particularly pronounced for women in LMICs, where stigma surrounding reproductive health can be profound. Social perceptions often frame chronic illness as a limitation, and some women report being questioned about their ability to conceive, carry a pregnancy safely, or raise healthy children. For example, in Indonesia, stigma can be reinforced by cultural expectations of women to fulfil traditional roles as mothers, which may amplify guilt or shame when complications arise.53 For women with GDM, it has been repeatedly reported that embarrassment, guilt and shame are common54–58 and frequently linked to the belief that their personal behaviours ‘caused’ the condition. Weight‐related stigma intersects notably with the experience of GDM. Women with higher BMI may feel explicitly or implicitly blamed through public and clinical discourse, interactions with healthcare providers,59 family members or their community, 47 leading to internalised shame and avoidance of care, reluctance to disclose symptoms and social withdrawal. 47 Depression and anxiety The risk of both depression and anxiety is higher in women with diabetes compared with those without. A survey reported that 40% of women with type 2 diabetes had depression compared with 7% of those without diabetes.60 Qualitative studies highlight anxiety in women struggling to meet glucose targets51 and among young women with type 1 diabetes contemplating pregnancy. 44 However, one study comparing mental health in women with (n = 518) and without (n = 282) type 1 diabetes during late pregnancy and postpartum reported no differences in pregnancy‐related depression or stress.61 For women with GDM, the risk of mental health problems both during and after pregnancy is well documented. A systematic review of mental disorders in GDM estimated that approximately 28% report depressive symptomatology around the time of diagnosis, with 13% continuing postpartum.62 Anxiety and stress are also more prevalent in this population.63 Internalised blame regarding the diagnosis may further intensify emotional burden, particularly for women who perceive their condition as self‐inflicted. 47 Evidence from systematic reviews of GDM experiences indicates that women can undergo low mood, fear, sadness, and despair following diagnosis, often linked to the intensity and stress of self‐management and personal behaviour changes in GDM. 46 ,56,57,64 High levels of anxiety about the health of their unborn child have also been reported.65 This emotional strain can impact women's behaviours: food avoidance or excessive dietary control and concealing self‐monitoring of blood glucose.54 Disordered eating and body image Evidence suggests that the medicalisation of diet in GDM can exacerbate disordered eating, particularly for women with prior weight concerns or previous disordered eating.66 A study of women with (n = 37) and without (n = 45) GDM showed some association with anxiety and eating in the women with GDM, although the study was underpowered.67 A study of women with type 2 diabetes of reproductive age described disordered eating functioning as a coping strategy to manage a range of emotional experiences, including guilt and shame that in turn perpetuate a recurring pattern of maladaptive eating behaviours.68 Diabetes distress Diabetes distress is reported in women with type 2 diabetes during pregnancy, encompassing feelings of being overwhelmed and trapped in a ‘cycle of distress’.69 In one study of 76 pregnant women with type 1 or 2 diabetes, prevalence was 22% overall and 15% in type 2 diabetes,70 and a systematic review with a narrative synthesis of studies of women with type 1 diabetes transitioning into pregnancy reported that women experience diabetes distress and anxiety in this period. 45 ,68,70 A recent scoping review71 found that women with type 1 diabetes reported similar emotional experiences during pregnancy over the past two decades. These include fears about their baby's physical health, concerns about their own health, challenges managing blood glucose (including hypoglycaemia and hyperglycaemia), feelings of guilt, loss of control and vulnerability, and, in some cases, a lack of trust in healthcare providers and the wider health system. However, no studies were identified that systematically addressed these concerns in routine clinical care. Many women reported that healthcare providers rarely discussed these issues, leaving pregnancy‐related diabetes distress largely unspoken, internalised, and unsupported.71 For women with GDM, data are limited; however, one study (n = 100) found a third reported diabetes distress, which was associated with adverse pregnancy outcomes.69 Emotional support Current evidence suggests women with diabetes in pregnancy often feel inadequately supported. Women with type 1 diabetes described a lack of empathy from healthcare teams. 50 ,52 Women with GDM frequently reported abandonment postpartum, with little support in managing future type 2 diabetes risk.63,65,70,72 Many prioritise their baby's needs over their own, sometimes neglecting screening or self‐care.73 Women with type 2 diabetes reported healthcare professionals often hold negatively biased views related to their age or body size. 42 They desire meaningful support as the burden of type 2 diabetes and pregnancy heighten stress and adversely impact their overall well‐being. 43 Social support There is a growing body of evidence that peer and social support may help reduce psychosocial burden, reduce isolation, improve coping, and promote self‐care. 43 , 45 , 47 A literature review of the transition to motherhood among women with type 1 diabetes highlighted the importance of supportive relationships in mitigating emotional burden and facilitating adjustment. 45 Regarding women with type 2 diabetes, a qualitative evidence synthesis reported that social and peer support may reduce feelings of isolation, stigma, and responsibility, while enhancing coping and self‐management. 43 A scoping review of qualitative and mixed methods GDM studies identified supportive networks as important in alleviating distress and improving engagement with care. 47 Evidence gaps and conclusion Despite growing recognition of the psychosocial burden of diabetes in pregnancy, critical gaps remain. To address these, there is a need for: Expanding research to capture the experiences of women with type 1 and type 2 diabetes prior to, during, and after pregnancy, including psychosocial challenges beyond those documented in GDM.Designing and evaluating interventions that address the psychosocial needs of women with pre‐existing diabetes in pregnancy.Developing and implementing validated clinical tools to screen for and manage psychosocial factors as part of routine pregnancy care. Expanding research to capture the experiences of women with type 1 and type 2 diabetes prior to, during, and after pregnancy, including psychosocial challenges beyond those documented in GDM. Expanding research to capture the experiences of women with type 1 and type 2 diabetes prior to, during, and after pregnancy, including psychosocial challenges beyond those documented in GDM. Designing and evaluating interventions that address the psychosocial needs of women with pre‐existing diabetes in pregnancy. Designing and evaluating interventions that address the psychosocial needs of women with pre‐existing diabetes in pregnancy. Developing and implementing validated clinical tools to screen for and manage psychosocial factors as part of routine pregnancy care. Developing and implementing validated clinical tools to screen for and manage psychosocial factors as part of routine pregnancy care. Overall, the evidence highlights stigma, emotional distress, and inadequate support as common psychosocial challenges across all forms of diabetes in pregnancy. Women with type 1 diabetes often face anxiety related to the demands of intensive management, while those with type 2 diabetes experience additional stigma and the marginalisation of their reproductive health needs. For women with GDM, the psychosocial impact is especially well documented, with guilt, shame, and heightened anxiety frequently reported. Despite these challenges, psychosocial concerns remain under‐recognised in clinical practice. Addressing these gaps through tailored research and integrated care approaches will be crucial to ensuring that women's emotional as well as medical needs are consistently met. PERIMENOPAUSE/MENOPAUSE AND DIABETES For those living with diabetes, menopause transition is associated with a higher background prevalence of psychological morbidity than those without diabetes.74 While there is growing recognition of its significance,75 the intersectionality of diabetes and menopause remains under‐researched.76 Consequently, the evidence to inform comprehensive management for women living with diabetes as they transition to menopause is limited. Perimenopause is a period leading up to menopause. During this transition period, many women report symptoms such as vasomotor fluctuation (hot flushes), disrupted sleep, and alterations in sexual functioning that can negatively affect their overall quality of life.77,78 This is a time when women are also particularly vulnerable to experiencing psychological difficulties such as anxiety and depressive symptoms.79 Diabetes self‐management Women with diabetes describe the metabolic changes resulting from the menopause as significantly increasing the cognitive load of self‐management.80 It is a time when previously stable treatment regimens become less effective with notable glucose variability. For those with type 1 diabetes this can be coupled with uncertainty as they are challenged to differentiate hypoglycaemia symptoms from the hormonally driven vasomotor symptoms associated with perimenopause.81,82 This can drive a cycle of intense glucose monitoring and uncertainty, leading to feeling of being overwhelmed, and ‘failing’ at managing their diabetes and ultimately diabetes distress and burnout.81–83 Deterioration in concordance with treatment regimens and declining quality of life have been reported among women with type 2 diabetes during this life stage. These are pronounced in those experiencing anxiety or depression.84,85 For this group, physical and psychosocial symptoms associated with menopause transition can also exacerbate anxiety or depression, thus creating a negative cycle in their self‐management behaviours. Cardiovascular health Regardless of diabetes type, women with diabetes have heightened cardiovascular risks that worsens during the menopausal transition, resulting in a two‐to threefold increase in cardiovascular mortality compared with those without diabetes.86,87 Psychological factors play a major role in both the onset and progression of hypertension during the menopausal transition, with anxiety, depressive symptoms, and elevated stress emerging as key contributors in women during this life stage.88,89 Cardiovascular risks can be further complicated with the coexistence of weight gain.90 A large UK population‐based study included adults with diabetes (n = 22, 685) of which 38% (n = 8, 53) were women.91 Overall, women with diabetes had a 22% higher risk develop heart failure than men with diabetes, with hazard ratios of 2.2 (95% CI: 1.9–2.5) versus 1.8 (95% CI: 1.7–2.0) for men. Current cardiovascular risk scores are not adequately sensitive for women, and they do not incorporate the psychosocial burden.92,93 Women report feeling dismissed and unsupported by healthcare professionals when trying to raise their concerns. Consequently, they feel discouraged to seek help and this can negatively impact their self‐care and health‐seeking behaviours.74 Sexual health and the menopause Sexual health and relational well‐being are important but often overlooked components of the menopausal experience for women with diabetes. Menopause is a significant independent predictor of female sexual dysfunction.94 Postmenopausal women with type 2 diabetes reported lower sexual quality of life than those without diabetes, with higher sexual Menopause Specific Quality of life (MENQOL) scores reflecting the interaction of menopausal symptoms and diabetes‐related complications.85 Qualitative accounts illustrate that menopausal and diabetes‐related changes can strain intimate relationships, diminish body image, and limit opportunities for discussing sexual concerns within clinical care.81,82 Evidence gaps and conclusion Transition to menopause is a critical and under‐recognised time of vulnerability for women living with diabetes. Future research should consider: Examining how hormonal changes, psychological health, and diabetes self‐management interact across the transition to menopause for women living with diabetes.Exploring how diabetes treatments, education, and clinical support should be adapted during this life stage.Developing and validating women‐sensitive cardiovascular risk assessment models that integrate psychosocial burden and menopausal status. Examining how hormonal changes, psychological health, and diabetes self‐management interact across the transition to menopause for women living with diabetes. Examining how hormonal changes, psychological health, and diabetes self‐management interact across the transition to menopause for women living with diabetes. Exploring how diabetes treatments, education, and clinical support should be adapted during this life stage. Exploring how diabetes treatments, education, and clinical support should be adapted during this life stage. Developing and validating women‐sensitive cardiovascular risk assessment models that integrate psychosocial burden and menopausal status. Developing and validating women‐sensitive cardiovascular risk assessment models that integrate psychosocial burden and menopausal status. Menopause is a period of heightened psychological and metabolic vulnerability for women living with diabetes, which interact to undermine quality of life and diabetes self‐management. However, transitioning to menopause remains poorly recognised or reduced to vasomotor symptoms (hot flushes) within clinical encounters. During this stage of life, women with diabetes report their experiences are overlooked, and their concerns are inadequately addressed and remain invisible within clinical contexts. SEXUAL FUNCTION AND DIABETES The impact of diabetes can extend beyond reproductive physiology into intimate and relational domains, exerting significant effects on sexual function. Sexual dysfunction (SD) is a common although under‐recognised complication among women living with diabetes, affecting those with type 1 and type 2 diabetes. SD significantly influences psychological well‐being, intimate relationships, and overall quality of life. Although the drivers of SD vary across type 1 and type 2 diabetes, the available evidence highlights the overlapping psychosocial burden, physiological disruption, relational challenges, and the broader demands of living with diabetes. Despite the significant impact on quality of life, sexual health remains under‐researched and under‐discussed in clinical care, and women's concerns are often left unaddressed.95 Prevalence While estimates vary considerably, SD is widely prevalent among women with diabetes. Women with type 1 diabetes have a threefold increased likelihood of experiencing SD compared with women without diabetes.96 SD can present earlier in women with type 1 diabetes, often preceding age‐related complications and leading to distress and reduced quality of life.97 Similarly, among women with type 2 diabetes, the prevalence SD ranges from 20% to 87% demonstrating a substantial risk to this group.98,99 Biopsychosocial mechanisms Female sexual functioning relies on the coordinated interaction of neurological, vascular, and hormonal systems.99,100 In diabetes, these systems may be disrupted through neuropathy, vascular impairment, or hormonal imbalance, all of which contribute to SD. Psychosocial factors frequently exert a strong influence. Diabetes distress and depression frequently co‐exist with SD.101,102 In a cross‐sectional study among women with type 1 diabetes (n = 171), depression was a significant predictor of SD (OR 1.28 [1.12–1.46]).103 Additionally, anxiety and impaired emotional well‐being have been reported as contributing factors for SD in women with type 1 or type 2 diabetes.103–106 Negative body image, often intensified by weight stigma in type 2 diabetes or by visible devices and injection sites, further undermines sexual confidence and desire.107,108 Although glycaemia and diabetes‐related complications can exacerbate symptoms,109 psychosocial variables consistently explain substantial variance in SD across type 1 and type 2 diabetes. These factors may also influence physiological processes, including hormonal regulation and neural pathways related to sexual response. Relational and interpersonal dynamics SD in women with diabetes has meaningful implications for intimate relationships. Women type 1 and type 2 diabetes commonly report guilt, frustration, or shame associated with sexual difficulties, while partners may experience disappointment or reduced satisfaction.110,111 Fear of hypoglycaemia, more frequently aligned to women with type 1 diabetes can further disrupt sexual intimacy, contributing to avoidance of sexual activity and negative relational experiences.96,112 Consequently, partner support plays an important role in mitigating distress and improving sexual and emotional well‐being.113 Interpersonal difficulties may also extend to wider aspects of daily life undermining social support networks and diminishing overall quality of life.114 Technology and body image Diabetes technologies, while beneficial for diabetes management, may introduce challenges for sexual intimacy. Participants in an online survey (n = 289), of which 53% (n = 152) were women, reported interference with sexual activity due to discomfort and heightened body image anxiety associated with continuous glucose monitoring sensors and insulin pumps.115 More recently, concerns about device dislodgement were reported and associated with reduced sexual activity.116 Integration and diagnosis Despite the high prevalence and considerable impact of SD, many women report that healthcare professionals rarely initiate discussions about sexual health and they would prefer if clinicians did so.107,117 This contributes to ongoing underdiagnosis and undertreatment, despite the availability of both psychological and medical interventions.118 Effective assessment requires a holistic, culturally sensitive approach that incorporates both physiological and psychosocial dimensions of sexual functioning.119 Evidence gaps and conclusion Despite the prevalence and potential psychosocial impact of SD in women with diabetes, interventions to support women remain scarce. Future research should focus on: Developing interventions and routine care that address women's sexual health needs and recognise sexual well‐being as a key factor in overall psychosocial well‐being.Developing a better understanding of the impact of diabetes‐related stigma, body image concerns, and sexual identity across the life course for women with diabetes.Developing clinical screening tools and care pathways to address the marginalisation of sexual well‐being for women with diabetes. Developing interventions and routine care that address women's sexual health needs and recognise sexual well‐being as a key factor in overall psychosocial well‐being. Developing interventions and routine care that address women's sexual health needs and recognise sexual well‐being as a key factor in overall psychosocial well‐being. Developing a better understanding of the impact of diabetes‐related stigma, body image concerns, and sexual identity across the life course for women with diabetes. Developing a better understanding of the impact of diabetes‐related stigma, body image concerns, and sexual identity across the life course for women with diabetes. Developing clinical screening tools and care pathways to address the marginalisation of sexual well‐being for women with diabetes. Developing clinical screening tools and care pathways to address the marginalisation of sexual well‐being for women with diabetes. The intersection of sexual health with other psychosocial challenges, such as disordered eating, diabetes distress, and stigma, creates a complex picture in which women's needs are often overlooked in both clinical and research agendas. Furthermore, cultural taboos around female sexuality and systemic constraints within clinical consultations may further silence discussion. CONCLUSION Women living with diabetes experience considerable psychosocial challenges during key life stages, including menstruation, pregnancy, menopause, and sexual functioning. Hormonal changes intersect with diabetes self‐management, stigma, and healthcare systems in ways that significantly affect emotional well‐being, perceived control, and quality of life. Despite this, psychosocial experiences remain insufficiently recognised within the predominantly biomedical models of diabetes care. During menstruation and menopause, women report increased glycaemic variability, increased self‐management burden, and psychological distress. Often, women navigate these challenges without adequate clinical guidance. Despite women reporting feelings such as anxiety, guilt, and stigma, they experience inadequate emotional support. Sexual dysfunction is also highly prevalent and closely linked to diabetes distress yet remains under‐recognised and under‐treated within routine diabetes care. Overall, the evidence highlights a persistent gap between the lived experiences and current models of care for women with diabetes. Future research and clinical practice must move beyond glycaemic outcomes alone to ensure that women's emotional and psychosocial needs are systematically identified and addressed. FUNDING INFORMATION This research received no specific grant from any funding agency in the public, commercial, or not‐for‐profit sectors. CONFLICT OF INTEREST STATEMENT GN: Employee of Diabeter, an independent clinic which was acquired by Medtronic. The research presented here was independently performed and there are no conflicts of interest. Independently involved in a producer‐initiated study with Inreda Diabetic B.V., for which she receives no renumeration other than (co‐)authorship. Industry research discounts (Dexcom; appr. EUR 5000 on the purchase of sensors) and speaker fees (Dexcom, Sanofi) were paid directly to employer Radboudumc. POSITIONALITY STATEMENT The research team comprised predominantly of women members, including those with lived experience of diabetes, alongside clinicians, researchers, and academics from diverse career stages and international contexts with expertise in diabetes care and research. While this composition facilitated sensitivity to the gendered dimensions of living with diabetes, we acknowledge that our perspectives are shaped by both professional and personal positions, and efforts were made to incorporate diverse perspectives throughout. Supporting information Data S1.